Wooridul Huebrain Limited

KSE 118000.KS

Wooridul Huebrain Limited EPS (Diluted) for the year ending December 31, 2023: USD -0.11

Wooridul Huebrain Limited EPS (Diluted) is USD -0.11 for the year ending December 31, 2023, a 86.33% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Wooridul Huebrain Limited EPS (Diluted) for the year ending December 31, 2022 was USD -0.77, a -1,268.70% change year over year.
Wooridul Huebrain Limited EPS (Diluted) for the year ending December 31, 2021 was USD 0.07, a -69.15% change year over year.
Wooridul Huebrain Limited EPS (Diluted) for the year ending December 31, 2020 was USD 0.21, a 270.77% change year over year.
Wooridul Huebrain Limited EPS (Diluted) for the year ending December 31, 2019 was USD -0.13, a 69.88% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

KSE: 118000.KS

Wooridul Huebrain Limited

CEO	Ms. Soo-Kyung Kim
IPO Date	May 5, 2006
Location	South Korea
Headquarters	156, No. 202, Dream Building)
Employees	23
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Medical Instruments

Description

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.

Key trends

Past 5 years